Table of Contents
Fetching ...

Percentile-based probabilistic optimization for systematic and random uncertainties in radiation therapy

Albin Fredriksson, Erik Engwall, Jenneke de Jong, Johan Sundström

TL;DR

This work tackles the challenge of explicitly controlling the probability of meeting clinical goals under geometric uncertainties in radiation therapy. It introduces a percentile-based probabilistic optimization framework that models full treatment courses and uses a fast dose-approximation via interpolation to enable practical optimization. The method demonstrated clear improvements in goal fulfillment probabilities and OAR sparing for both a VMAT prostate case and a PBS brain case, outperforming conventional margin-based and worst-case approaches. By linking explicit probabilistic targets to treatment planning, the approach provides an interpretable and potentially more robust framework suitable for both photon and proton therapies and adaptable to future fractionation or adaptive strategies.

Abstract

Geometric uncertainty can degrade treatment quality in radiation therapy. While margins and robust optimization mitigate these effects, they provide only implicit control over clinical goal fulfillment probability. We therefore develop a probabilistic planning framework using a percentile-based optimization function that targets a specified probability of clinical goal fulfillment. Systematic and random uncertainties were explicitly modeled over full treatment courses. A scenario dose approximation method based on interpolation between a fixed set of doses was used, enabling efficient simulation of treatment courses during optimization. The framework was evaluated on a prostate case treated with volumetric-modulated arc therapy (VMAT) and a brain case treated with pencil beam scanning (PBS) proton therapy. Plans were compared to conventional margin-based and worst-case robust optimization using probabilistic evaluation. For the prostate case, probabilistic optimization improved organ at risk (OAR) sparing while maintaining target coverage compared to margin-based planning, increasing average OAR goal fulfillment probability by 13.3 percentage points and reducing 90th percentile OAR doses by an average of 3.5~Gy. For the brain case, probabilistic optimization improved target minimum dose passing probabilities (e.g., 88\% vs.~22\% for $D_{95}$) and brainstem maximum dose passing probability (70\% vs.~30\%), while maintaining comparable or improved OAR sparing compared to worst-case optimization. Probabilistic optimization enables explicit and interpretable control over goal fulfillment probabilities. Combining full treatment course modeling with efficient approximate dose calculation, the proposed framework improved the trade-off between target coverage and OAR sparing compared to conventional planning approaches in both photon and proton therapy.

Percentile-based probabilistic optimization for systematic and random uncertainties in radiation therapy

TL;DR

This work tackles the challenge of explicitly controlling the probability of meeting clinical goals under geometric uncertainties in radiation therapy. It introduces a percentile-based probabilistic optimization framework that models full treatment courses and uses a fast dose-approximation via interpolation to enable practical optimization. The method demonstrated clear improvements in goal fulfillment probabilities and OAR sparing for both a VMAT prostate case and a PBS brain case, outperforming conventional margin-based and worst-case approaches. By linking explicit probabilistic targets to treatment planning, the approach provides an interpretable and potentially more robust framework suitable for both photon and proton therapies and adaptable to future fractionation or adaptive strategies.

Abstract

Geometric uncertainty can degrade treatment quality in radiation therapy. While margins and robust optimization mitigate these effects, they provide only implicit control over clinical goal fulfillment probability. We therefore develop a probabilistic planning framework using a percentile-based optimization function that targets a specified probability of clinical goal fulfillment. Systematic and random uncertainties were explicitly modeled over full treatment courses. A scenario dose approximation method based on interpolation between a fixed set of doses was used, enabling efficient simulation of treatment courses during optimization. The framework was evaluated on a prostate case treated with volumetric-modulated arc therapy (VMAT) and a brain case treated with pencil beam scanning (PBS) proton therapy. Plans were compared to conventional margin-based and worst-case robust optimization using probabilistic evaluation. For the prostate case, probabilistic optimization improved organ at risk (OAR) sparing while maintaining target coverage compared to margin-based planning, increasing average OAR goal fulfillment probability by 13.3 percentage points and reducing 90th percentile OAR doses by an average of 3.5~Gy. For the brain case, probabilistic optimization improved target minimum dose passing probabilities (e.g., 88\% vs.~22\% for ) and brainstem maximum dose passing probability (70\% vs.~30\%), while maintaining comparable or improved OAR sparing compared to worst-case optimization. Probabilistic optimization enables explicit and interpretable control over goal fulfillment probabilities. Combining full treatment course modeling with efficient approximate dose calculation, the proposed framework improved the trade-off between target coverage and OAR sparing compared to conventional planning approaches in both photon and proton therapy.
Paper Structure (16 sections, 12 equations, 5 figures, 2 tables)

This paper contains 16 sections, 12 equations, 5 figures, 2 tables.

Figures (5)

  • Figure 1: Overview of the proposed probabilistic optimization framework with approximate treatment course scenario dose calculation. (a) Fraction doses are precalculated on a grid of setup shifts. (b) A treatment course scenario is generated by sampling a systematic setup error and combining it with per-fraction random errors, and its constituent fraction doses are computed by interpolation in the grid (dotted lines indicate the nearest neighbors). (c) Multiple treatment course scenarios are sampled to form an empirical distribution of scenario doses. (d) Probabilistic optimization is performed using a percentile-based objective, targeting the fraction $\beta$ of best function values over the treatment course scenarios, i.e., the $100\beta$-percentile.
  • Figure 2: DVHs and 10--90th percentile DVH bands for the prostate case treated with VMAT for (a) the probabilistic method and (b) the conventional margin-based method. ROIs displayed are CTV (black), rectum (brown), bladder (yellow), anal canal (cyan), bulbus (magenta), external (green). Nominal DVHs are shown as dashed lines. Two points at (50 Gy, 40%) and (70 Gy, 40%) have been added to both graphs for reference.
  • Figure 3: Transversal slices and dose distributions of the prostate case treated with VMAT for (a) the probabilistic method and (b) the conventional margin-based method. ROIs displayed are CTV (black), CTV + 0.7 cm margin (white), rectum (brown), bladder (yellow), anal canal (cyan), bulbus (magenta), external (green).
  • Figure 4: DVHs and 10--90th percentile DVH bands for the brain case treated with PBS for (a) the probabilistic method and (b) the conventional robust optimization. ROIs displayed are CTV (black), brainstem core (cyan), brainstem surface (brown), optic nerve left (yellow), chiasm (magenta), brain (blue), external (green). Nominal DVHs are shown as dashed lines. Two points at (40 Gy, 20%) and (57 Gy, 95%) have been added to both graphs for reference.
  • Figure 5: Transversal slices and dose washes of the brain case treated with PBS for (a) the probabilistic method and (b) the conventional robust optimization. ROIs displayed are CTV (black), brainstem core (cyan), brainstem surface (brown), optic nerve left (yellow), chiasm (magenta), brain (blue), external (green).